✦ LIBER ✦

A phase II study of days 1 and 8 combination of docetaxel plus gemcitabine for the second-line treatment of patients with advanced non-small-cell lung cancer and good performance status

✍ Scribed by Cobo, Manuel; Gutiérrez, Vanesa; Alcaide, Julia; Alés, Inmaculada; Villar, Esther; Gil, Silvia; Durán, Gema; Martínez, Joaquina; Carabantes, Francisco; Bretón, Juan J.; Benavides, Manuel

Book ID: 119319570
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 244 KB
Volume: 56
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2006.12.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Irinotecan plus gemcitabine vs irinoteca

Irinotecan plus gemcitabine vs irinotecan for the second-line treatment of patients with advanced non-small-cell lung cancer pretreated with docetaxel and cisplatin: a multicentre, randomised, phase II study

✍ Georgoulias, V; Kouroussis, C; Agelidou, A; Boukovinas, I; Palamidas, P; Stavrin 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

A phase II study of docetaxel (D) and ge

A phase II study of docetaxel (D) and gemcitabine (G) as second-line treatment in patients (pts) with advanced non-small cell lung cancer (NSCLC)

✍ Agelaki, S.; Papadakis, E.; Tsiafaki, X.; Rapti, A.; Toubis, M.; Bania, E.; Kalb 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Front-line treatment of advanced non-sma

Front-line treatment of advanced non-small cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial

✍ Georgoulias, V; Kourousis, Ch; Androulakis, N; Kakolyris, S; Dimopoulos, MA; Pap 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Open, Randomized, Phase II Study of Sing

Open, Randomized, Phase II Study of Single-Agent Gemcitabine and Docetaxel as First- and Second-Line Treatment in Patients with Advanced Non–Small-Cell Lung Cancer

✍ Christian Manegold; Gabriele Koschel; Dagmar Hruska; Kathrin Schott-von-Römer; J 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 155 KB

Phase II trial of weekly docetaxel and g

Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer

✍ Sujith Kalmadi; Giles McNeill; Mellar Davis; David Peereboom; David Adelstein; T 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 68 KB

A phase II study of docetaxel and vinore

A phase II study of docetaxel and vinorelbine combination chemotherapy in patients with advanced non-small cell lung cancer

✍ J Bennouna; A Monnier; A Rivière; B Milleron; E Lemarie; V Trillet-Lenoir; K Sou 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 97 KB